Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan starts oral cancer screening programme:

This article was originally published in Clinica

Executive Summary

The Taiwanese Department of Health has started a national oral cancer screening programme. It will use OraTest, a five-minute mouthwash product that shows up pre-symptomatic cancerous lesions. Zila, which manufactures the product, says it is also hoping to introduce it in Singapore, Hong Kong, China and Japan. Oral cancer is one of the most common forms of cancer in Asia due to high smoking rates and the habit of chewing a carcinogenic mixture of betel nut, lime leaf and frequently, tobacco. Phoenix, Arizona based Zila has applied to have the product approved in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel